<DOC>
	<DOCNO>NCT02481609</DOCNO>
	<brief_summary>The purpose research study evaluate use NAC treatment anosmia ( loss sense smell ) . This drug already approve Food Drug Administration ( FDA ) oral pulmonary ( lung ) inhale use medical condition . However , research evidence medication may promote nerve recovery ( help nerve work well damage ) . Since anosmia involve nerve problem , believe nasal spray may help treat anosmia . The medication use many year condition , without safety problem .</brief_summary>
	<brief_title>NAC Trial Anosmia</brief_title>
	<detailed_description />
	<mesh_term>Olfaction Disorders</mesh_term>
	<mesh_term>Acetylcysteine</mesh_term>
	<mesh_term>N-monoacetylcystine</mesh_term>
	<criteria>adult least 18 year age document microsmia anosmia University Pennsylvania Smell Identification Test . patient must evidence active sinonasal disease nasal endoscopy CT MRI negative CT MRI adult unable consent individual yet adult ( infant , child , teenager ) pregnant woman , prisoner , employee subordinate , patient know sensitivity NAC severe asthma patient sinus central disease CT MRI imaging .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Loss Smell</keyword>
	<keyword>Olfaction</keyword>
	<keyword>Hyposmia</keyword>
</DOC>